GreenSpace Labs is a company that focuses on identifying human conditions that can benefit from treatment with cannabinoids, developing different formulations, and performing clinical research. They are tackling the problem of lack of clinical evidence and standardization for cannabinoid-based medicine.
Location: United States
Mentions in press and media 3
| Date | Title | Description |
| 01.08.2024 | Greenspace Labs Inc. Welcomes Dr. Jill Simonian, PharmD to Advisory Board | Greenspace Labs Boosts its Advisory Board with the Addition of Dr Jill Simonian, PharmD, a Nationally Recognized Expert in Cannabis Pharmacology SAN DIEGO, CA, USA, August 1, 2024 /EINPresswire.com/ -- Greenspace Labs Inc. (GSL), a leader i... |
| 12.03.2024 | Ocean State Controlled Botanicals and Greenspace Labs Announce Partnership to Develop Cannabinoid-Based Medical Products | Ocean State Controlled Botanicals LLC dba Hangar 420 and Greenspace Labs Inc. Announce Strategic Partnership to Market Cannabinoid-Based Therapeutic Products SAN DIEGO, CA, USA, March 12, 2024 /EINPresswire.com/ -- Ocean State Controlled Bo... |
| 10.03.2023 | Greenspace Labs Announces Funding for a Clinical Trial to Study a Cannabinoid-Based Treatment for IBS | Greenspace Labs' funding for a fifty person pilot clinical trial to study the effectiveness of a cannabinoid-based treatment for irritable bowel syndrome (IBS). SAN DIEGO, CALIFORNIA, UNITED STATES, March 10, 2023 /EINPresswire.com/ -- The ... |